title: Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitro.
abstract: This is the first morphological study of interleukin-2-stimulated human peripheral blood mononuclear (PBM) cells resulting in lymphokine-activated killer (LAK) cell activity against human glioma-derived tumor cells in vitro, in which high-resolution differential interference video light microscopy, scanning electron microscopy, and transmission electron microscopy were used. A subset of cells within the LAK cell population are the effector cells and have an asymmetric cellular architecture characteristic of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. Upon binding to target cells, the LAK effector cell nucleus is positioned away from the target cell, whereas the granules, Golgi apparatus, and microtubules orient toward the target cell. These LAK-glioma cell conjugates form very tight plasma membrane bonds with numerous interdigitations, and vesicles were found in the small extracellular spaces between the cells. This morphology was not observed in unstimulated PBM-glioma cell co-cultures. Glioma-derived cells react to LAK effector cells by blebbing, becoming round, and rapidly detaching from the substrate. The injured glioma-derived cells had a highly condensed cytoplasm and chromatin, lobular nucleus, and severe plasma membrane blebs, which are consistent with an apoptotic rather than an osmotic lysis mechanism of cell death. This study provides morphological evidence that supports a common cytotoxic mechanism for CTLs, NK cells, and LAK effector cells. The cytotoxic mechanism is based on the local exocytosis of vesicles by the effector cell into the small extracellular space between the effector-target cell conjugate. Granules found in CTLs, NK cells, and LAK cells contain a pore-forming protein that inserts holes in the target cell's plasma membrane through which a lethal substance(s) not yet identified is thought to enter the cell.
authors.affiliation: Surgical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.
authors.forename: G R
authors.initials: GR
authors.lastname: Hook
authors.forename: M A
authors.initials: MA
authors.lastname: Greenwood
authors.forename: D
authors.initials: D
authors.lastname: Barba
authors.forename: B
authors.initials: B
authors.lastname: Ikejiri
authors.forename: S N
authors.initials: SN
authors.lastname: Chen
authors.forename: E H
authors.initials: EH
authors.lastname: Oldfield
authors.forename: R J
authors.initials: RJ
authors.lastname: Weber
authors.forename: L M
authors.initials: LM
authors.lastname: Muul
mesh_terms: D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D005910:Glioma / Q000276:immunology / Q000648:ultrastructure; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D007700:Kinetics; D008214:Lymphocytes / Q000145:classification / Q000276:immunology*; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D007376:Interleukin-2